Elevated serum neurofilament light chain (sNfL) levels in patients with multiple sclerosis, Alzheimer’s disease, Parkinson’s and Huntington’s diseases, motor neuron diseases, cerebrovascular accidents, hereditary peripheral neuropathies, and impairments associated with traumatic brain injury (16–21). The gene discussed is NEFL; the disease is early-onset autosomal dominant Alzheimer disease.